Giant Gastric Gastrointestinal Stromal Tumor (GIST)

dc.contributor.authorNavarrete, Andres
dc.contributor.authorMomblan, Dulce
dc.contributor.authorAlmenara, Raul
dc.contributor.authorLacy, Antonio
dc.date.accessioned2017-08-16T13:33:30Z
dc.date.available2017-08-16T13:33:30Z
dc.date.issued2016
dc.description.abstractGastrointestinal stromal tumors (GIST) represent 0.1–3 % of gastrointestinal malignancy. Surgery is the mainstay of treatment, but in high-risk tumors, imatinib can help to achieve better oncological outcomes. We present a rare case of a patient with gastric GIST with very aggressive evolution in a short period of time despite the use of neoadjuvant therapy with imatinib.
dc.format.extent3
dc.identifier.citationJ Gastrointest Surg (2017) 21:202-204
dc.identifier.urihttp://hdl.handle.net/11447/1578
dc.identifier.urihttp://dx.doi.org/10.1007/s11605-016-3196-x
dc.language.isoen_US
dc.publisherSpringer
dc.subjectGIST
dc.subjectGastric
dc.subjectImatinib
dc.titleGiant Gastric Gastrointestinal Stromal Tumor (GIST)
dc.typeArtículo

Files

Original bundle
Now showing 1 - 1 of 1
Loading...
Thumbnail Image
Name:
Giant Gastric Gastrointestinal Stromal Tumor .pdf
Size:
173.91 KB
Format:
Adobe Portable Document Format
Description:
Resumen